News
Washington DC - Almost six years ago, Fatiha and Abellatif Abderraziq stood in the parking lot of Washington children’s ...
Zacks Investment Research on MSN13d
BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric StudyBioMarin BMRN has announced positive results from the phase III PEGASUS study evaluating Palynziq (pegvaliase) in adolescents aged 12-17 years with phenylketonuria (PKU). The study achieved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback